FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Tobramycin Lyophilized Powder for Injection
Status: Currently in Shortage
»Date first posted: 08/24/2020
»Therapeutic Categories: Anti-Infective; Pediatric

Expand all

Fresenius Kabi USA, LLC (Revised 09/15/2020)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1.2 g, pharmacy bulk package, tray of 6 vials (NDC 63323-303-51) Backordered. Next release expected November 2020. Delay in manufacturing Other
1.2 g, pharmacy bulk package, tray of 6 vials (NDC 63323-303-55), Novaplus Backordered. Next release expected November 2020. Delay in manufacturing Other

X-GEN Pharmaceuticals, Inc. (New 08/24/2020)

Company Contact Information:
866-390-4411

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1.2 g, pharmacy bulk package, bottle (NDC 39822-0412-1) Available XGen continues to manufacture at full capacity. Plans are underway to increase production. Timeline TBD. Demand increase for the drug
1.2 g, pharmacy bulk package, pack of 6 bottles (NDC 39822-0412-6) Available XGen continues to manufacture at full capacity. Plans are underway to increase production. Timeline TBD. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English